Device Trial Radar · NCT07784673
OsteoFlo HydroFiber Ambispective Evaluation
Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
Feb 1, 2027
Study completion Feb 1, 2027
Sponsor
- Lead sponsor
- SurGenTec LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 25, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFiber when used to promote fusion in the lumbar spine.
Conditions
- OsteoFlo HydroFiber
Interventions
OsteoFlo HydroFiberDevice
Observational study of subjects previously implanted with OsteoFlo HydroFiber.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Qualitative FusionTime frame: 6 months post-op
3 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Duly Health and Care
Naperville, Illinois
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.